IL139405A0 - Reduced particle size form of 1-(6-chloronaphth-2-ylsulphonyl)-4-[4-(4-pyridyl) benzoyl] piperazine - Google Patents
Reduced particle size form of 1-(6-chloronaphth-2-ylsulphonyl)-4-[4-(4-pyridyl) benzoyl] piperazineInfo
- Publication number
- IL139405A0 IL139405A0 IL13940599A IL13940599A IL139405A0 IL 139405 A0 IL139405 A0 IL 139405A0 IL 13940599 A IL13940599 A IL 13940599A IL 13940599 A IL13940599 A IL 13940599A IL 139405 A0 IL139405 A0 IL 139405A0
- Authority
- IL
- Israel
- Prior art keywords
- chloronaphth
- ylsulphonyl
- piperazine
- pyridyl
- benzoyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9809350.3A GB9809350D0 (en) | 1998-05-02 | 1998-05-02 | Novel salt |
PCT/GB1999/001316 WO1999057112A1 (en) | 1998-05-02 | 1999-04-27 | Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl] piperazine |
Publications (1)
Publication Number | Publication Date |
---|---|
IL139405A0 true IL139405A0 (en) | 2001-11-25 |
Family
ID=10831311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13940599A IL139405A0 (en) | 1998-05-02 | 1999-04-27 | Reduced particle size form of 1-(6-chloronaphth-2-ylsulphonyl)-4-[4-(4-pyridyl) benzoyl] piperazine |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1084118A1 (sk) |
JP (1) | JP2002513789A (sk) |
KR (1) | KR20010043216A (sk) |
CN (1) | CN1308629A (sk) |
AU (1) | AU3719699A (sk) |
BR (1) | BR9910176A (sk) |
CA (1) | CA2331041A1 (sk) |
EE (1) | EE200000638A (sk) |
GB (1) | GB9809350D0 (sk) |
HU (1) | HUP0102394A3 (sk) |
IL (1) | IL139405A0 (sk) |
NO (1) | NO20005498D0 (sk) |
PL (1) | PL343705A1 (sk) |
SK (1) | SK16522000A3 (sk) |
WO (1) | WO1999057112A1 (sk) |
ZA (1) | ZA200006036B (sk) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ID23991A (id) | 1997-09-30 | 2000-06-14 | Daiichi Seiyaku Co | Turunan-turunan sulfonil |
TWI288745B (en) | 2000-04-05 | 2007-10-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
US7365205B2 (en) | 2001-06-20 | 2008-04-29 | Daiichi Sankyo Company, Limited | Diamine derivatives |
PT1569912E (pt) | 2002-12-03 | 2015-09-15 | Pharmacyclics Llc | Derivados 2-(2-hidroxibifenil-3-il)-1h-benzoimidazole-5- carboxamidina como inibidores do fator viia |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA56197C2 (uk) * | 1996-11-08 | 2003-05-15 | Зенека Лімітед | Гетероциклічні похідні |
AU7453498A (en) * | 1997-05-30 | 1998-12-30 | Takeda Chemical Industries Ltd. | Sulfonamide derivatives, their production and use |
ID23991A (id) * | 1997-09-30 | 2000-06-14 | Daiichi Seiyaku Co | Turunan-turunan sulfonil |
-
1998
- 1998-05-02 GB GBGB9809350.3A patent/GB9809350D0/en not_active Ceased
-
1999
- 1999-04-27 SK SK1652-2000A patent/SK16522000A3/sk unknown
- 1999-04-27 CN CN99808217A patent/CN1308629A/zh active Pending
- 1999-04-27 EE EEP200000638A patent/EE200000638A/xx unknown
- 1999-04-27 KR KR1020007012149A patent/KR20010043216A/ko not_active Application Discontinuation
- 1999-04-27 WO PCT/GB1999/001316 patent/WO1999057112A1/en not_active Application Discontinuation
- 1999-04-27 CA CA002331041A patent/CA2331041A1/en not_active Abandoned
- 1999-04-27 AU AU37196/99A patent/AU3719699A/en not_active Abandoned
- 1999-04-27 PL PL99343705A patent/PL343705A1/xx not_active Application Discontinuation
- 1999-04-27 BR BR9910176-9A patent/BR9910176A/pt not_active IP Right Cessation
- 1999-04-27 EP EP99919395A patent/EP1084118A1/en not_active Withdrawn
- 1999-04-27 HU HU0102394A patent/HUP0102394A3/hu unknown
- 1999-04-27 IL IL13940599A patent/IL139405A0/xx unknown
- 1999-04-27 JP JP2000547082A patent/JP2002513789A/ja active Pending
-
2000
- 2000-10-25 ZA ZA200006036A patent/ZA200006036B/en unknown
- 2000-11-01 NO NO20005498A patent/NO20005498D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EE200000638A (et) | 2002-04-15 |
ZA200006036B (en) | 2002-01-25 |
HUP0102394A3 (en) | 2003-01-28 |
JP2002513789A (ja) | 2002-05-14 |
BR9910176A (pt) | 2001-01-09 |
HUP0102394A2 (hu) | 2001-12-28 |
WO1999057112A1 (en) | 1999-11-11 |
CA2331041A1 (en) | 1999-11-11 |
NO20005498L (no) | 2000-11-01 |
GB9809350D0 (en) | 1998-07-01 |
NO20005498D0 (no) | 2000-11-01 |
EP1084118A1 (en) | 2001-03-21 |
PL343705A1 (en) | 2001-08-27 |
SK16522000A3 (sk) | 2001-05-10 |
AU3719699A (en) | 1999-11-23 |
CN1308629A (zh) | 2001-08-15 |
KR20010043216A (ko) | 2001-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL146707A0 (en) | Novel use of 1-[4-(5-cyanoindol-3-yl) butyl]-4-(2-carbamoyl-benzofuran-5-yl)- piperazine and its physiologically acceptable salts | |
AU2151399A (en) | Novel piperidines and piperazines as platelet aggregation inhibitors | |
DE60038365D1 (en) | 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- oder pyridylpyrimidine als endothelinrezeptorantagonisten | |
ES8506696A1 (es) | Un procedimiento para la preparacion de 1-(4-(4,4-dialquil-2,6-piperidindion-1-il)butil)piperazinas. | |
SI1252144T1 (sl) | Substituirani glutarimidi in njihova uporaba kot inhibitorji proizvajanja IL-12 | |
PL347635A1 (en) | New piperazine and piperidine compounds | |
NZ325845A (en) | 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives, preparation and pharmaceutical use thereof | |
EE200100498A (et) | 1,4-asendatud piperasiin-, 1,4-asendatud piperidiin- ja 1-asendatud 4-alkülidenüülpiperidiinühendidning nende raviotstarbeline kasutamine | |
HU9802129D0 (en) | New piperazine and piperidine derivatives | |
DE69829989D1 (en) | 1-(2-naphthyl) und 1-(2-azanaphthyl)-4-(1-phenylmethyl)piperazine als dopamin d4 subtype liganden | |
NZ299788A (en) | 4-substituted(4-(1-adamantyl)phenyl) derivatives | |
IL139405A0 (en) | Reduced particle size form of 1-(6-chloronaphth-2-ylsulphonyl)-4-[4-(4-pyridyl) benzoyl] piperazine | |
IL121461A0 (en) | Use of 1-[4-[4-aryl (or heteroaryl)-1-piperazinyl]butyl]-1H-azole derivatives | |
HUP9800511A3 (en) | Phosphorylized derivatives of 4-{4-[4-(hydroxy-diphenyl)-1-pipe | |
IL143779A0 (en) | Piperidine and piperazine derivatives as inhibitors of the abeta fibril formation | |
HUP0104797A3 (en) | Method for preparing 4-(3-pyridinyl)-1h-imidazole and the intermediates used | |
IL157061A0 (en) | Process for the preparation of (3-cyano-1h-indol-7-yl) (4-(4-fluorophenethyl) piperazin-1-yl)-methanone and salts thereof | |
HK1062683A1 (en) | Synthesis of 4-(piperidyl) (2-pyridyl)methanone-(E)-=-methyloxime and its salts. | |
AU1224495A (en) | 1-(2-(1H-inden-3-yl)ethyl)-4-(naphth-1-yl)piperazine derivatives, their preparation and their application in therapeutics | |
NZ336129A (en) | Micro-particulate form of a tetrahydropyridin derivative (SR 57746) | |
AU6165798A (en) | Non-sedating histamine antagonist compounds, compositions and methods of use thereof | |
NZ308110A (en) | Polymorphs of lesopitron dihydrochloride, ie 2-[4-[4-[4- (chloropyrazole-1-yl)butyl]-1-piperazinyl]pyrimidine, and its hydrated forms, preparation and pharmaceutical compositions | |
HU9700274D0 (en) | (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)-piperazin-1-yl]-phenoxy}-butiric acid as inhibitor of celle-adhesion | |
AU6705396A (en) | 1-(2-(2,3-Dihydro-1H-inden-1-yl)ethyl)-4-(naphthalen-1-YL) piperazine derivatives, their preparation and their application in therapeutics | |
HUP0105124A3 (en) | 1-(6-methylpyridine-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone and method for its preparation |